Group One Trading
IBB icon

Group One Trading’s iShares Biotechnology ETF IBB Stock Holding History

Group One Trading’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$499K Buy
+2,622
New +$451K ﹤0.01% 3498
2025
Q4 		– Sell
-17,045
Closed -$2.46M – 8582
2025
Q3 		$2.46M Buy
17,045
+1,116
+7% +$152K ﹤0.01% 2099
2025
Q2 		$2.02M Buy
+15,929
New +$1.96M ﹤0.01% 2136

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Group One Trading's IBB Position: Q2 2026 in Review

Group One Trading opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 2,622 shares worth $499K. The stake represents ﹤0.01% of the portfolio and ranks #3498 among its holdings. This is a return to the name: Group One Trading previously reported a position in IBB as recently as Q3 2025.

Group One Trading first reported a position in IBB in Q2 2025 and has held it in 3 quarters since. The position peaked at $2.46M in Q3 2025. 958 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Group One Trading held 2,622 shares of iShares Biotechnology ETF worth $499K as of Q2 2026.
  • iShares Biotechnology ETF was a new Group One Trading position in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3498 holding.
  • Group One Trading first reported a position in iShares Biotechnology ETF in Q2 2025 and has held it in 3 quarters since.
  • Group One Trading's iShares Biotechnology ETF position peaked at $2.46M in Q3 2025.
  • 958 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.